Literature DB >> 30910260

Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients.

Letizia Santinelli1, Maura Statzu2, Alessandra Pierangeli3, Federica Frasca4, Alessia Bressan5, Claudia Pinacchio6, Chiara Nonne7, Ombretta Turriziani8, Guido Antonelli9, Gabriella d'Ettorre10, Carolina Scagnolari11.   

Abstract

Following recent attention focused on IL-32 as an important component involved in the inflammatory cytokine network, we speculated that IL-32's action on IFN-γ and IFN-γ secreting T cell subsets may help sustain the immune activation and dysregulation found in patients with HIV-1 achieving viral suppression. To explore this hypothesis, transcript levels of IL-32 and IFN-γ were evaluated in PBMC from 139 virologically suppressed HIV-1-infected patients and from 63 healthy individuals by Real Time RT-PCR assays. IL-32 and IFN-γ mRNA levels were also analyzed in CD4+ T cells, CD14+ monocytes and lamina propria lymphocytes (LPL) of the gut district in a subgroup of HIV-1-infected subjects. IFN-γ secreting CD4+ (Th1) and CD8+ (Tc1) T cell subset frequencies were evaluated in LPL by multiparametric flow cytometry. Gene expression results revealed that IL-32 and IFN-γ levels in PBMC from HIV-1-positive patients were significantly elevated compared to those from healthy donors, correlated with each other and increased with patient age. Both IL-32 and IFN-γ genes were also more strongly expressed in CD4+ T cells than in CD14+ monocytes. By contrast, IL-32 levels in LPL were comparable to those measured in PBMC, while IFN-γ levels were higher in PBMC than those in LPL. Negative correlations were found between IL-32 levels and the frequencies of Th1 and Tc1 subsets in gut mucosa. Collectively, our results provide the first evidence that IL-32 levels remain elevated in treated HIV-1-infected patients and correlate with IFN-γ, Th1 and Tc1 subsets.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gut; HIV; IFN gamma; IL-32; T cell subtypes

Year:  2019        PMID: 30910260     DOI: 10.1016/j.cyto.2019.01.012

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A.

Authors:  Etiene Moreira Gabriel; Tomas Raul Wiche Salinas; Annie Gosselin; Etienne Larouche-Anctil; Madeleine Durand; Alan L Landay; Mohamed El-Far; Cécile L Tremblay; Jean-Pierre Routy; Petronela Ancuta
Journal:  AIDS       Date:  2021-10-01       Impact factor: 4.632

2.  The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.

Authors:  Lesley R de Armas; Christina Gavegnano; Suresh Pallikkuth; Stefano Rinaldi; Li Pan; Emilie Battivelli; Eric Verdin; Ramzi T Younis; Rajendra Pahwa; Siôn L Williams; Raymond F Schinazi; Savita Pahwa
Journal:  Front Immunol       Date:  2021-08-31       Impact factor: 7.561

3.  Altered T-Cell Subsets are Associated with Dysregulated Cytokine Secretion of CD4+ T Cells During HIV Infection.

Authors:  Di Wang; Yu Jiang; Yangzi Song; Yongqin Zeng; Cuilin Li; Xinyue Wang; Ying Liu; Jiang Xiao; Yaxian Kong; Hongxin Zhao
Journal:  J Inflamm Res       Date:  2021-10-07

4.  Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.

Authors:  Gabriella d'Ettorre; Gregorio Recchia; Marco Ridolfi; Guido Siccardi; Claudia Pinacchio; Giuseppe Pietro Innocenti; Letizia Santinelli; Federica Frasca; Camilla Bitossi; Giancarlo Ceccarelli; Cristian Borrazzo; Guido Antonelli; Carolina Scagnolari; Claudio Maria Mastroianni
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.